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Dipeptidylpeptidase-III (DPP-III) from goat brain was puriﬁed and characterized using Arginyl-Arginyl-4-methoxy-β-
naphthylamide (Arg-Arg-4mβNA) substrate. This enzyme retained its activity in native 10% polyacrylamide gel when stained
using Arg-Arg-4mβNA. The activity was signiﬁcantlyincreased by 100mM chloride. Studies for its inhibition with some peptides
andchemical inhibitorsrevealed thatLeu-Trp-Met-Arg-Phe-Ala wasmostpotent inhibitorfollowedby Arg-Phe-Ala andGly-Phe-
Leu.Allthestudiedchemicalinhibitorscaused40–50%inhibitionat1mM.MetalionshelpedtoregainactivityofEDTApretreated
enzyme. ZnCl2 at 50μM almost completely restored the enzyme activity. Further ZnCl2 and CoCl2 exerted protective eﬀects on
EDTA pretreated enzyme for its susceptibility to DTNB inhibition. Therefore, DPP-III is a metalloprotease with the involvement
of cysteine residues either located at the catalytic site or involved in regulation.
1.Introduction
DPP-III (EC 3.4.14.4) of the goat brain is a dipeptidy-
laminopeptidase which removes N-terminal dipeptide from
Arg-Arg-4mβNA at pH 8.5. The enzyme was recently
puriﬁed and characterized [1]a n df o u n dt ob ea ﬀected by
thiolcompoundsand metal ions[2].The enzyme iscytosolic
and ubiquitous in all studied tissues [3]. It hydrolysed
Leu-enkephalin and other bioactive peptides and displayed
micromolar aﬃnity for enkephalins thereby suggesting its
involvement in regulating enkephalin disposition [2, 4]. It
is also reported in the cerebrospinal ﬂuid of patients with
acute pain [5]. All the studied analgesic and antihypertensive
drugs inhibited the enzyme [6]. In the present study, it has
been demonstrated that the enzyme activity is retained in
Davis gel electrophoresis at pH 8.3. Understanding of cat-
alytic mechanisms, structural features of protease, and their
inhibitors are very important to explore their applications in
medicinal ﬁeld. So present study is carried outto understand
its inhibitors.
2.Materials
The goat brains were obtained from a local slaughter house
in Kurukshetra. Arg-Arg-4mβNA was of Bachem Fein-
chemikalien Co., Budendorf, Germany. Ethylene diamine
tetraacetic acid (EDTA), Tris-HCl, dialysis bags, Polyacry-
lamide, N, N
 -methylene bisacrylamide, ammonium per-
sulphate, and TEMED were procured from Himedia. Fast
Garnet GBC was from Sigma Chemical Co., St. Louis, Mo,
USA. The routine pipetting was done with micropipettes
from Tarson and very small volumes were pipetted out
using Hamilton syringes. The digital spectrophotometer
fromSystronicswasusedtorecordtheabsorbanceat520nm.
3.Methods
3.1. Puriﬁcation and Assay of DPP. DPP was puriﬁed and
assayed with Arg-Arg-4mβNA as substrate at pH 8.5 (Tris-
HCl, 50mM, containing 100mM NaCl and 1mM β-
mercaptoethanol (β-ME) [1]. One unit of enzyme activity2 Enzyme Research
was deﬁned as the amount of enzyme that liberated
1nanomole of 4mβNA from the substrate per minute under
assay conditions.
3.2. Determination of Optimum Concentration of Chloride
Ions. T h ee n z y m ew a si n c u b a t e dw i t hT r i s - H C lb u ﬀer
(50mM, pH 8.5 containing 1mM β-ME) with diﬀerent
concentrations of NaCl (0 to 1000mM) at 37◦Cf o r1 0m i n .
T h ea c t i v i t yi se x p r e s s e da sp e r c e n t a g eo fm a x i m u m .
3.3. Activity Staining. For activity staining, the 10% Davis
gel was prepared [7]. Before loading the protein samples, the
polymerized gel was pre-electrophoresed for 2h at a current
of4mA byusingresolving gelbuﬀer.Puriﬁedprotein(25μg)
was loaded on gel and run at a constant current of 4mA
at 4◦C. The gel was cut in two halves. One half was stained
with Coomassie Brilliant dye and other half was stained for
enzyme activity by thoroughly washing the gel with assay
buﬀerand incubating the gelwith substrate at 37◦Can dthen
putting the gel in Fast Garnet GBC (1mg/mL) for 15min for
colour development.
3.4.Reversal ofEDTAInhibition byMetal Ions. Puriﬁed DPP-
III was treated with 2.5mM EDTA for 10min and then
extensively dialysed against 50mM Tris-HCl buﬀer, pH 7.0.
This enzyme was assayed in the presence of diﬀerent metal
ionsatdiﬀerentconcentration.TheEDTApretreatedenzyme
was preincubated with appropriate salts in assay buﬀer at
37◦C for 10min. The reaction was started by adding 150μM
ofsubstrate andactivity isexpressed aspercentageofcontrol.
Likewise eﬀect of DTNB was studied on EDTA pretreated
enzyme in presence of ZnCl2 and CoCl2.
4.Resultsand Discussion
The puriﬁed enzyme retained its activity during elec-
trophoresis at pH 8.3, in Davis gel as shown in Figure 1.
The activity band obtained with Arg-Arg-4mβNA as speciﬁc
substrate corresponded well with the protein band stained
with Coomassie Brilliant blue. This suggests that polyacry-
lamide can be used for its immobilization. The enzyme
was activated by Cl− ions and maximum activation was
achieved at 100mM ﬁnal concentration, which accounted
formore than 1.5-foldincrease inenzyme activity (Figure 2).
Therefore 100mM NaCl was the component of assay buﬀer.
Thisproperty issimilar tothatofDPP-III enzyme ofanterior
pituitary [8]. Beyond 100mM, enzyme activity decreased
with increase in NaCl concentration.
4.1. Reversal of EDTA Inhibition by Metal Ions. Incubation
of pure DPP-III with 2.5mM EDTA resulted in 60%
inhibition of enzyme activity. Dialysis after removal of
chelating agent did not restore the activity. The suppressed
activity could be partially restored by adding metal ions
like ZnCl2,C o C l 2,N i C l 2,F e S O 4,a n dM g C l 2 but none of
the metal ions could completely restore the enzyme activity.
Zn2+ at 50μM almost completely restored enzyme activity
(∼97%) (Figure 3). These results support our earlier studies
Figure 1: Davis gel electrophoresis of DPP-III after staining with
coomassie brilliant blue dye (gel 1). Gel 2 shows activity staining of
DPP-III.
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Figure 2: Eﬀect of NaCl on activity of DPP-III.
with o-phenanthroline thereby conﬁrming this enzyme to
be a metalloprotease having Zn2+ at the active site. Our
results are in agreement with human placental DPP-III [9],
whereas Co2+ was most eﬀective in restoring the activity of
EDTA pretreated DPP-III from human RBCs [10]. Ca2+ and
Co2+ were most eﬀective in restoring the activity of EDTA
pretreated guinea pig brain DPP-III [11]. On the otherhand,
untreated DPP-III was activated by Co2+ and inhibited by
Zn2+,N i 2+,a n dC u 2+.C a 2+,M g 2+,M n 2+,a n dF e 2+ were
slightly inhibitory [2].Enzyme Research 3
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Figure 3: Eﬀect of metal ions on 2.5mM EDTA pretreated enzyme
in presence of (a) ZnCl2,( b )C o C l 2,( c )N i C l 2,( d )F e S O 4,( e )a n d
MgCl2.
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Figure 4:EDTA (2.5mM)pretreated enzyme inthe presence of (a),
DTNB (b) DTNB and CoCl2,( c )D T N Ba n dZ n C l 2.
Relationship between binding of metal ions and cysteine
r e s i d u e so nD P P - I I Iw a si n v e s t i g a t e db yi n a c t i v a t i o no f
EDTA-treated enzyme with DTNB in the presence and
absence of Co2+ and Zn2+.R e s u l t sa r es h o w ni nFigure 4.
Bothmetalionsexertedsigniﬁcantprotectiveeﬀect.However
Zn2+ was more protective than Co2+. It appears that binding
of metal ions inﬂuence reactivity and accessibility of thiol
group(s) essential for enzyme activity.
Therefore it can be concluded that enzyme is a metal-
loprotease with the involvement of cysteine residues either
located on the catalytic site or involved in regulation. Several
other metalloenzymes having –SH group at the active site
have also been reported earlier [12, 13].
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